Global Cervical Cancer Elimination

FIGO joins WHO Working Group on Increase Access to Screening and Treatment in global effort to eliminate cervical cancer

Cervical Cancer and HIV

One woman dies of cervical cancer every two minutes, and HIV-infected women are at fives times greater risk. Task-sharing could help.

Staging for OVFTP malignancies

A new report from FIGO's IJGO discusses updates to the ways in which cancers of the ovaries, fallopian tube and peritoneum are staged...

FIGO Global Declaration on Cervical Cancer Elimination

FIGO membership aligns with WHO and the UNFPA to eliminate Cervical Cancer.

HPV rates are going down

The linking of a virus to some cases of cervical cancer development and the introduction of a vaccine to prevent it has been one of the biggest medical breakthroughs of our time.

New hereditary cancer risk tool launched by UK charity

A new tool has been developed by a UK charity to help people identify if their family history puts them at greater risk of developing ovarian and other cancers. Ovarian Cancer Action has created the Hereditary Cancer Risk Tool, which lays out a series of questions regarding a person's family...

The voice for women's health

Making FIGO’s voice, and that of our member societies, much louder and more relevant at this years World Health Assembly, Geneva...

Addressing Gynecological Oncology at WHA71

FIGO delivered an Official Side Event on Gynecological Oncology – Early Detection and Prevention at the 71 st World Health Assembly...

Six months of breast cancer treatment ‘could be as effective as 12 in some women’

Six months of targeted drug therapy could potentially be as effective as treatment lasting 12 months for women with a type of early stage breast cancer. This is according to unpublished clinical trial results. Roughly nine in ten women taking trastuzumab - sold under the brand name Herceptin - for...

HPV vaccine found to be ‘safe and effective’

The human papillomavirus (HPV) vaccine offered to teenage girls in the UK is safe and effective in its protection against a virus that can cause cervical cancer. This is according to a new independent review by the Cochrane Group. It looked at 26 trials covering 73,428 girls or women and found that...